Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

XOMA Corp. Stock

Price
Target price
€22.20

€22.20

-0.890%
-0.2
-0.890%
€91.89

€91.89

 
Buy 10 Sell 0
Buy 10
Sell 0
16:00 / Tradegate WKN: A2ATUH / Symbol: XOMA / Name: XOMA / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
12.12.25
2.78%
buy
€38.50
11.12.25
-2.63%
buy
11.12.25
-2.63%
buy
12.09.25
-30.63%
buy
14.06.25
10.00%
buy
31.05.25
3.74%
buy
Show more
Your prediction
Pros and Cons of XOMA Corp. in the next few years
Wizard

XOMA Corp. Stock

XOMA Corp. shows a slight decrease today, losing -€0.200 (-0.890%) compared to yesterday.
XOMA Corp. is currently one of the favorites of our community with 10 Buy predictions and no Sell predictions.
Based on the current price of 22.2 € the target price of 91 € shows a potential of 309.91% for XOMA Corp. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for XOMA Corp. stock. Negative votes have not been in the majority for any criteria for this stock
What does XOMA do?

Pros and Cons of XOMA Corp. in the next few years

Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of XOMA Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
XOMA Corp. -0.890% -2.609% 2.752% -13.846% 3.704% 6.667% -31.749%
Ardelyx Inc. 15.670% -7.887% 19.572% 19.401% 18.404% 129.428% 3.304%
Evolus Inc -0.930% -9.504% -25.763% -56.200% -19.633% -54.375% -6.809%
Champions Oncology Inc - 7.143% 2.564% -36.842% 3.448% 50.000% -34.426%

Comments

XOMA Royalty (NASDAQ:XOMA) had its "buy" rating reaffirmed by analysts at Benchmark Co..
Ratings data for XOMA provided by MarketBeat
Show more

Benchmark Co. 
0
Report Share
12.12.25 Buy 2.78%
Prediction Buy
Perf. (%) -2.63%
Target price 38.498
Change
Ends at 11.12.26

XOMA Royalty (NASDAQ:XOMA) was given a new $45.00 price target on by analysts at Leerink Partners. They now have an "outperform" rating on the stock.
Ratings data for XOMA provided by MarketBeat
Show more

SVB Leerink LLC 
0
Report Share
11.12.25

XOMA Royalty (NASDAQ:XOMA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Ratings data for XOMA provided by MarketBeat
Show more

HC Wainwright 
0
Report Share
11.12.25 Buy -2.63%
Show more
Not a member yet? Sign up for free!

News

XOMA Revenue Jumps 39% in Fiscal Q2
XOMA Revenue Jumps 39% in Fiscal Q2

XOMA (NASDAQ:XOMA), a biotechnology royalty aggregator, reported second quarter results on August 13, 2025, for the period ending June 30. The company’s revenue (GAAP) reached $13.1 million for Q2

TheMotleyFool 
0 13.08.25